Benzinga | Jan 26, 2022 04:06PM EST

Vertex Sees FY22 Product Revenue $8.4B-$8.6B

Full Year 2022 Financial Guidance

Vertex today provided full year 2022 financial guidance. Vertex's product revenue guidance is primarily based on expectations for continued strong performance of TRIKAFTA in the U.S., and KAFTRIO outside the U.S. Vertex's product revenue guidance reflects management's expectations for approved products in countries where Vertex has already secured reimbursement.

Vertex's guidance is summarized below:

FY 2022



Product revenues $8.4 to $8.6 billion



Combined GAAP R&D and SG&A expenses (2) $3.30 to $3.45 billion

Combined Non-GAAP R&D and SG&A expenses (2) $2.70 to $2.75 billion

Non-GAAP effective tax rate 21% to 22%

Key Business Highlights